Noetik logo

Noetik

Recent Finacing

Series A

Recent Raise

$40M

Noetik uses self-supervised and transformer-based machine learning applied to a multimodal spatial omics atlas and high-throughput in vivo CRISPR Perturb-Map system to discover precision cancer therapy targets.

Founded 2022
California, United States
11-50
Private
noetik.ai

Highlights

Focus Areas

Biotechnology
Life Science

Recent Investors

Financials

$54M

Total Raised

2

Funding rounds

16

Investors


Team

Upgrade to view the team

See the team members at Noetik.